Triptorelin pamoate for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Feb 2021: Trial started, NCT05557604
  2. 28 Sep 2022: Trial registered, NCT05557604

The trials

NCT05557604: Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

State
Under way
Phase
Phase 2
People
146 planned
Started
2 Feb 2021
Primary completion
2 Feb 2024
Arms
arm 2
Results
None posted
  1. 2 Feb 2021: Trial started
  2. 28 Sep 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Decapeptyl, Salvacyl, Trelstar, Triptorelin Embonate.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.